Literature DB >> 23089503

Managing hypoxemia during minimally invasive thoracic surgery.

Jens Lohser1.   

Abstract

An ever-increasing number of thoracic procedures are being performed through minimally invasive techniques. Although the incidence of hypoxemia during one-lung ventilation (OLV) has decreased over the years, it remains an issue in roughly 10% of cases. Algorithms for the management of OLV hypoxemia have to be adapted to the thoracoscopic approach, in particular the need for optimal surgical exposure. With appropriate planning and caution, most of the treatment modalities for OLV hypoxemia can be applied to the thoracoscopy setting, with some modifications.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23089503     DOI: 10.1016/j.anclin.2012.08.006

Source DB:  PubMed          Journal:  Anesthesiol Clin        ISSN: 1932-2275


  4 in total

Review 1.  Intraoperative crisis resource management during a non-intubated video-assisted thoracoscopic surgery.

Authors:  Jose Navarro-Martínez; Carlos Gálvez; María Jesus Rivera-Cogollos; María Galiana-Ivars; Sergio Bolufer; Francisco Martínez-Adsuar
Journal:  Ann Transl Med       Date:  2015-05

2.  One-Lung Ventilation with Additional Ipsilateral Ventilation of Low Tidal Volume and High Frequency in Lung Lobectomy.

Authors:  Yong Feng; Jianyue Wang; Yang Zhang; Shiduan Wang
Journal:  Med Sci Monit       Date:  2016-05-11

3.  Effects of prostaglandin E1 nebulization of ventilated lung under 60%O2 one lung ventilation on patients' oxygenation and oxidative stress: a randomised controlled trial.

Authors:  Pengyi Li; Lianbing Gu; Qingming Bian; Jing Tan; Dian Jiao; Fei Wu; Zeping Xu; Lijun Wang
Journal:  Respir Res       Date:  2020-05-13

4.  Thoracoscopic partial lung resection following pneumonectomy: a report of three cases.

Authors:  Hidenori Goto; Mingyon Mun; Shohei Mori; Joji Samejima; Yosuke Matsuura; Masayuki Nakao; Hirohumi Uehara; Ken Nakagawa; Sakae Okumura
Journal:  J Cardiothorac Surg       Date:  2019-11-04       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.